{"name":"Butylscopolamine","slug":"butylscopolamine","kind":"substance","abbreviations":[],"systematic":null,"aliases":["n-butylscopolammonium","N-butylscopolammonium ion","N-butylscopolammonium cation","butylscopolammonium","butilescopolamina","Hsdb 7642","Scopolamine N-N-Butyl","n-butylscopolamine","butylscopolamine-bromide","Bromide, Butylscopolammonium"],"brands":[],"scraped":true,"has_structure":true,"cid":160883,"classes":[{"name":"anticholinergic","href":"/class/anticholinergic"}],"families":[{"name":"tropane","href":"/substituted/tropane"}],"physical":[{"label":"Molecular mass","value":"360.50 g/mol","copyable":false},{"label":"Predicted LogP","value":"2.6","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>21</sub>H<sub>30</sub>NO<sub>4</sub>+","copyable":true},{"label":"IUPAC name","value":"[(1R,2R,4S,5S)-9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate","copyable":true},{"label":"SMILES","value":"CCCC[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C","copyable":true},{"label":"InChI","value":"InChI=1S/C21H30NO4/c1-3-4-10-22(2)17-11-15(12-18(22)20-19(17)26-20)25-21(24)16(13-23)14-8-6-5-7-9-14/h5-9,15-20,23H,3-4,10-13H2,1-2H3/q+1/t15?,16-,17-,18+,19-,20+,22?/m1/s1","copyable":true},{"label":"InChIKey","value":"YBCNXCRZPWQOBR-MWGADRMYSA-N","copyable":true},{"label":"CAS number","value":"7182-53-8","copyable":true},{"label":"UNII","value":"2Z3E1OF81V","copyable":true},{"label":"PubChem CID","value":"160883","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"5 hours","copyable":false},{"label":"Excretion","value":"Kidney (50%) and fecal<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Routes of administration","value":"By mouth, rectal, intravenous","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"A","description":"Alimentary tract and metabolism"},{"code":"A03","description":"Drugs for functional gastrointestinal disorders"},{"code":"A03B","description":"Belladonna and derivatives, plain"},{"code":"A03BB","description":"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds"},{"code":"A03BB01","description":"Butylscopolamine"}],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"Scopolamine butylbromide binds to muscarinic M3 receptors in the gastrointestinal tract. This prevents acetycholine from binding to and activating the receptors which would result in contraction of the smooth muscle. The inhibition of contraction reduces spasms and their related pain during abdominal cramping.","side_effects":null,"effects":null,"usernotes":[{"user":"0xea","user_slug":"0xea","external":false,"note":{"substance":"Butylscopolamine","composite":false,"routes":[{"name":"Oral","dosage":"10mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":["Hydrobromide"],"sources":["Buscopan Plus: pharmacy"],"indications":[],"effects":["{xeff 'dry mouth'}"],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 2","act":null,"refs":[4]},{"jurisdiction":"Canada","status":"OTC (Pharmacist only)","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"GSL","act":null,"refs":[]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[5]},{"jurisdiction":"Other","status":"OTC","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Hyoscine_butylbromide"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/160883"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q27255822"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB09300"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1618102"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A145701"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=7182-53-8"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID4048145"},{"source":"Probes & Drugs","url":"https://www.probes-drugs.org/compound/PD132842"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Butylscopolamine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/2Z3E1OF81V"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 160883, Butylscopolamine. Accessed November 22, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/160883>https://pubchem.ncbi.nlm.nih.gov/compound/160883</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Butylscopolamine. UNII: 2Z3E1OF81V. Global Substance Registration System. Accessed November 22, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/2Z3E1OF81V>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/2Z3E1OF81V</a>","Tytgat GN. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs. 2007; 67(9):1343–1357. PMID 17547475. <a href='https://doi.org/10.2165/00003495-200767090-00007'>https://doi.org/10.2165/00003495-200767090-00007</a>","Hyoscine Butylbromide (AFT Pharmaceuticals Pty Ltd). Department of Health and Aged Care. <a href='https://www.tga.gov.au/resources/prescription-medicines-registrations/hyoscine-butylbromide-aft-pharmaceuticals-pty-ltd'>https://www.tga.gov.au/resources/prescription-medicines-registrations/hyoscine-butylbromide-aft-pharmaceuticals-pty-ltd</a>","Buscopan- n-butylscopolammonium bromide injection. DailyMed. 8 June 2020. <a href='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=858926e9-457e-47c2-b7c4-2d1c6bb13ea8'>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=858926e9-457e-47c2-b7c4-2d1c6bb13ea8</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 14:02:11","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 14:02:07","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 14:02:07","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 14:02:07","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 14:02:07","note":"no HMDB id"},{"source":"kegg","status":"missing","fetched_at":"2026-11-20 14:02:11","note":"no KEGG DRUG entry"},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 14:02:07","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 14:02:07","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 14:02:07","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 14:02:07","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 14:02:08","note":null}],"description":"Butylscopolamine is a anticholinergic substance."}